nodes	percent_of_prediction	percent_of_DWPC	metapath
Niflumic Acid—PTGS1—Montelukast—chronic obstructive pulmonary disease	0.224	1	CbGbCtD
Niflumic Acid—PLA2G1B—respiratory system—chronic obstructive pulmonary disease	0.023	0.0967	CbGeAlD
Niflumic Acid—PTGS2—leg—chronic obstructive pulmonary disease	0.0213	0.0895	CbGeAlD
Niflumic Acid—PLA2G1B—connective tissue—chronic obstructive pulmonary disease	0.0202	0.0851	CbGeAlD
Niflumic Acid—Leflunomide—CYP1A2—chronic obstructive pulmonary disease	0.0159	1	CrCbGaD
Niflumic Acid—SLC16A7—bronchus—chronic obstructive pulmonary disease	0.0159	0.067	CbGeAlD
Niflumic Acid—SLC16A7—trachea—chronic obstructive pulmonary disease	0.0143	0.0602	CbGeAlD
Niflumic Acid—PLA2G4A—respiratory system—chronic obstructive pulmonary disease	0.014	0.0589	CbGeAlD
Niflumic Acid—PLA2G4A—connective tissue—chronic obstructive pulmonary disease	0.0123	0.0518	CbGeAlD
Niflumic Acid—PLA2G1B—lung—chronic obstructive pulmonary disease	0.0122	0.0513	CbGeAlD
Niflumic Acid—PLA2G4A—bronchus—chronic obstructive pulmonary disease	0.0115	0.0485	CbGeAlD
Niflumic Acid—PLA2G4A—smooth muscle tissue—chronic obstructive pulmonary disease	0.0113	0.0474	CbGeAlD
Niflumic Acid—PLA2G4A—trachea—chronic obstructive pulmonary disease	0.0103	0.0435	CbGeAlD
Niflumic Acid—SLC16A7—lung—chronic obstructive pulmonary disease	0.0103	0.0432	CbGeAlD
Niflumic Acid—PLA2G4A—lung—chronic obstructive pulmonary disease	0.00743	0.0313	CbGeAlD
Niflumic Acid—SLC16A1—lung—chronic obstructive pulmonary disease	0.00654	0.0275	CbGeAlD
Niflumic Acid—PTGS1—respiratory system—chronic obstructive pulmonary disease	0.00552	0.0233	CbGeAlD
Niflumic Acid—PTGS2—respiratory system—chronic obstructive pulmonary disease	0.00528	0.0222	CbGeAlD
Niflumic Acid—PTGS1—connective tissue—chronic obstructive pulmonary disease	0.00486	0.0205	CbGeAlD
Niflumic Acid—PTGS2—connective tissue—chronic obstructive pulmonary disease	0.00465	0.0196	CbGeAlD
Niflumic Acid—PTGS1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00445	0.0187	CbGeAlD
Niflumic Acid—PTGS2—bronchus—chronic obstructive pulmonary disease	0.00435	0.0183	CbGeAlD
Niflumic Acid—PTGS2—smooth muscle tissue—chronic obstructive pulmonary disease	0.00425	0.0179	CbGeAlD
Niflumic Acid—PTGS1—trachea—chronic obstructive pulmonary disease	0.00408	0.0172	CbGeAlD
Niflumic Acid—PTGS2—trachea—chronic obstructive pulmonary disease	0.0039	0.0164	CbGeAlD
Niflumic Acid—PTGS1—lung—chronic obstructive pulmonary disease	0.00293	0.0123	CbGeAlD
Niflumic Acid—PTGS2—lung—chronic obstructive pulmonary disease	0.0028	0.0118	CbGeAlD
Niflumic Acid—PLA2G4A—Betamethasone—Prednisone—chronic obstructive pulmonary disease	0.00273	0.253	CbGdCrCtD
Niflumic Acid—PLA2G4A—Dexamethasone—Prednisone—chronic obstructive pulmonary disease	0.00273	0.253	CbGdCrCtD
Niflumic Acid—PLA2G4A—Dexamethasone—Prednisolone—chronic obstructive pulmonary disease	0.00267	0.247	CbGdCrCtD
Niflumic Acid—PLA2G4A—Betamethasone—Prednisolone—chronic obstructive pulmonary disease	0.00267	0.247	CbGdCrCtD
Niflumic Acid—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—TP53—chronic obstructive pulmonary disease	0.00123	0.0024	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.00122	0.00239	CbGpPWpGaD
Niflumic Acid—PTGS2—Overview of nanoparticle effects—TNF—chronic obstructive pulmonary disease	0.00122	0.00238	CbGpPWpGaD
Niflumic Acid—SLC16A7—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.00121	0.00236	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Platelet homeostasis—NOS3—chronic obstructive pulmonary disease	0.00119	0.00232	CbGpPWpGaD
Niflumic Acid—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—chronic obstructive pulmonary disease	0.00116	0.00226	CbGpPWpGaD
Niflumic Acid—UGT1A9—PPARA activates gene expression—CYP1A1—chronic obstructive pulmonary disease	0.00115	0.00225	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.00113	0.00222	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.00113	0.00221	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.00113	0.0022	CbGpPWpGaD
Niflumic Acid—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CYP1A1—chronic obstructive pulmonary disease	0.00112	0.0022	CbGpPWpGaD
Niflumic Acid—UGT1A9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.0011	0.00216	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—GC—chronic obstructive pulmonary disease	0.0011	0.00216	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.00109	0.00213	CbGpPWpGaD
Niflumic Acid—PLA2G4A—AGE/RAGE pathway—MMP9—chronic obstructive pulmonary disease	0.00109	0.00213	CbGpPWpGaD
Niflumic Acid—PTGS1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.00108	0.00212	CbGpPWpGaD
Niflumic Acid—PTGS1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.00107	0.0021	CbGpPWpGaD
Niflumic Acid—UGT1A9—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.00105	0.00205	CbGpPWpGaD
Niflumic Acid—UGT1A9—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.00104	0.00203	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.00103	0.00201	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—APIP—chronic obstructive pulmonary disease	0.001	0.00196	CbGpPWpGaD
Niflumic Acid—PTGS1—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.000992	0.00194	CbGpPWpGaD
Niflumic Acid—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	0.000991	0.00194	CbGpPWpGaD
Niflumic Acid—PTGS2—Overview of nanoparticle effects—IL6—chronic obstructive pulmonary disease	0.000981	0.00192	CbGpPWpGaD
Niflumic Acid—PTGS2—C-MYB transcription factor network—GSTM1—chronic obstructive pulmonary disease	0.000972	0.0019	CbGpPWpGaD
Niflumic Acid—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	0.000972	0.0019	CbGpPWpGaD
Niflumic Acid—UGT1A9—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.000965	0.00189	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	0.00094	0.00184	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000934	0.00183	CbGpPWpGaD
Niflumic Acid—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	0.000926	0.00181	CbGpPWpGaD
Niflumic Acid—UGT1A9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000921	0.0018	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000909	0.00178	CbGpPWpGaD
Niflumic Acid—PTGS1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000901	0.00176	CbGpPWpGaD
Niflumic Acid—PLA2G4A—AGE/RAGE pathway—EGFR—chronic obstructive pulmonary disease	0.000879	0.00172	CbGpPWpGaD
Niflumic Acid—UGT1A9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000847	0.00166	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000835	0.00163	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000817	0.0016	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—TGFB2—chronic obstructive pulmonary disease	0.000815	0.00159	CbGpPWpGaD
Niflumic Acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—chronic obstructive pulmonary disease	0.000805	0.00157	CbGpPWpGaD
Niflumic Acid—UGT1A9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000803	0.00157	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000792	0.00155	CbGpPWpGaD
Niflumic Acid—PTGS2—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.000787	0.00154	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—APIP—chronic obstructive pulmonary disease	0.000779	0.00152	CbGpPWpGaD
Niflumic Acid—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000774	0.00151	CbGpPWpGaD
Niflumic Acid—PTGS1—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	0.000762	0.00149	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000762	0.00149	CbGpPWpGaD
Niflumic Acid—PTGS1—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	0.00076	0.00149	CbGpPWpGaD
Niflumic Acid—PTGS1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000751	0.00147	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	0.000731	0.00143	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—HDAC2—chronic obstructive pulmonary disease	0.000731	0.00143	CbGpPWpGaD
Niflumic Acid—SLC16A7—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000724	0.00142	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000712	0.00139	CbGpPWpGaD
Niflumic Acid—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	0.000699	0.00137	CbGpPWpGaD
Niflumic Acid—PTGS1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.00069	0.00135	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000664	0.0013	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—PLAUR—chronic obstructive pulmonary disease	0.000659	0.00129	CbGpPWpGaD
Niflumic Acid—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—chronic obstructive pulmonary disease	0.000657	0.00129	CbGpPWpGaD
Niflumic Acid—PTGS1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000654	0.00128	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—GC—chronic obstructive pulmonary disease	0.000646	0.00126	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—APIP—chronic obstructive pulmonary disease	0.000646	0.00126	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—TGFB2—chronic obstructive pulmonary disease	0.000634	0.00124	CbGpPWpGaD
Niflumic Acid—PTGS2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	0.000629	0.00123	CbGpPWpGaD
Niflumic Acid—PTGS1—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	0.000619	0.00121	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—LEP—chronic obstructive pulmonary disease	0.000609	0.00119	CbGpPWpGaD
Niflumic Acid—SLC16A1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000608	0.00119	CbGpPWpGaD
Niflumic Acid—PTGS2—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	0.000605	0.00118	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000605	0.00118	CbGpPWpGaD
Niflumic Acid—PTGS2—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	0.000604	0.00118	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000603	0.00118	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.0006	0.00117	CbGpPWpGaD
Niflumic Acid—PTGS2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	0.000599	0.00117	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—TLR4—chronic obstructive pulmonary disease	0.000597	0.00117	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000596	0.00117	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—HDAC2—chronic obstructive pulmonary disease	0.000569	0.00111	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—NOS2—chronic obstructive pulmonary disease	0.000568	0.00111	CbGpPWpGaD
Niflumic Acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—chronic obstructive pulmonary disease	0.00056	0.0011	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.000556	0.00109	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000556	0.00109	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000554	0.00108	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000544	0.00106	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	0.00054	0.00106	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Platelet activation, signaling and aggregation—ALB—chronic obstructive pulmonary disease	0.000539	0.00105	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000526	0.00103	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000516	0.00101	CbGpPWpGaD
Niflumic Acid—SLC16A1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000515	0.00101	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—PLAUR—chronic obstructive pulmonary disease	0.000513	0.001	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000512	0.001	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—GC—chronic obstructive pulmonary disease	0.000502	0.000982	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000501	0.00098	CbGpPWpGaD
Niflumic Acid—PTGS2—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	0.000491	0.000961	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—MMP1—chronic obstructive pulmonary disease	0.000471	0.000922	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000467	0.000913	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—PLAU—chronic obstructive pulmonary disease	0.000463	0.000905	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.00046	0.000901	CbGpPWpGaD
Niflumic Acid—PTGS1—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	0.000449	0.000878	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000446	0.000873	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000432	0.000844	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000428	0.000837	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—NOS2—chronic obstructive pulmonary disease	0.000425	0.000831	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000424	0.00083	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—APIP—chronic obstructive pulmonary disease	0.000418	0.000817	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000418	0.000817	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.000417	0.000816	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—GC—chronic obstructive pulmonary disease	0.000416	0.000814	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000412	0.000806	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—CXCL8—chronic obstructive pulmonary disease	0.000405	0.000792	CbGpPWpGaD
Niflumic Acid—UGT1A9—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	0.000393	0.00077	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—IL1B—chronic obstructive pulmonary disease	0.000388	0.00076	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000387	0.000757	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000384	0.000751	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	0.000383	0.000749	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	0.000376	0.000735	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000375	0.000734	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000372	0.000728	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	0.000371	0.000726	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—MMP1—chronic obstructive pulmonary disease	0.000366	0.000717	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—MMP9—chronic obstructive pulmonary disease	0.000366	0.000717	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000364	0.000712	CbGpPWpGaD
Niflumic Acid—PTGS1—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	0.000362	0.000709	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—PLAU—chronic obstructive pulmonary disease	0.00036	0.000704	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	0.000358	0.0007	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	0.000358	0.0007	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—ALB—chronic obstructive pulmonary disease	0.000357	0.000699	CbGpPWpGaD
Niflumic Acid—PTGS2—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	0.000356	0.000697	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000353	0.00069	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000349	0.000682	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000349	0.000682	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000346	0.000676	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—NOS3—chronic obstructive pulmonary disease	0.000342	0.000668	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	0.000341	0.000667	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—GC—chronic obstructive pulmonary disease	0.000339	0.000664	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—NOS2—chronic obstructive pulmonary disease	0.00033	0.000646	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000327	0.00064	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000318	0.000622	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000315	0.000617	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	0.000315	0.000617	CbGpPWpGaD
Niflumic Acid—SLC16A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000309	0.000605	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000308	0.000603	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—TGFB1—chronic obstructive pulmonary disease	0.000302	0.000591	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000298	0.000583	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—EGFR—chronic obstructive pulmonary disease	0.000296	0.000579	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000293	0.000573	CbGpPWpGaD
Niflumic Acid—PTGS2—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	0.000288	0.000563	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—TNF—chronic obstructive pulmonary disease	0.000282	0.000551	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.00028	0.000548	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	0.000278	0.000544	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—ALB—chronic obstructive pulmonary disease	0.000278	0.000543	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000277	0.000541	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000275	0.000537	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000274	0.000537	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000271	0.00053	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GC—chronic obstructive pulmonary disease	0.000269	0.000527	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—NOS3—chronic obstructive pulmonary disease	0.000266	0.00052	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000264	0.000516	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.000253	0.000495	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000251	0.000491	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.00025	0.00049	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.00025	0.000489	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—TP53—chronic obstructive pulmonary disease	0.000249	0.000486	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000247	0.000484	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—ALB—chronic obstructive pulmonary disease	0.000247	0.000484	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—VEGFA—chronic obstructive pulmonary disease	0.000246	0.000481	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000245	0.000478	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000241	0.000472	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000237	0.000463	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000228	0.000446	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—IL6—chronic obstructive pulmonary disease	0.000227	0.000445	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000227	0.000445	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—TGFB1—chronic obstructive pulmonary disease	0.000226	0.000442	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000225	0.00044	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000225	0.00044	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.000224	0.000438	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000219	0.000428	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000213	0.000417	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.00021	0.00041	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	0.000205	0.000402	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000205	0.000401	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	0.000201	0.000394	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000199	0.00039	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000193	0.000377	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	0.000192	0.000375	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—VEGFA—chronic obstructive pulmonary disease	0.000191	0.000374	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.00019	0.000372	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000189	0.00037	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000188	0.000367	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—TP53—chronic obstructive pulmonary disease	0.000186	0.000364	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000185	0.000362	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000183	0.000358	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000179	0.000351	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—TGFB1—chronic obstructive pulmonary disease	0.000176	0.000344	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000175	0.000342	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.000171	0.000334	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	0.000169	0.000331	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000167	0.000327	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000166	0.000324	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000165	0.000324	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000158	0.000308	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000155	0.000304	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000154	0.000301	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000148	0.000289	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—HDAC2—chronic obstructive pulmonary disease	0.000148	0.000289	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000147	0.000288	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000145	0.000284	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000145	0.000283	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—ALB—chronic obstructive pulmonary disease	0.000145	0.000283	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—TP53—chronic obstructive pulmonary disease	0.000145	0.000283	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000139	0.000271	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000137	0.000269	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—KL—chronic obstructive pulmonary disease	0.000137	0.000268	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.000136	0.000265	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.000135	0.000265	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000134	0.000263	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000133	0.00026	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000129	0.000253	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000128	0.000251	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000127	0.000248	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000122	0.000239	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.00012	0.000235	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000118	0.000231	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—ALB—chronic obstructive pulmonary disease	0.000113	0.00022	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000112	0.000219	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000108	0.000211	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—ERBB3—chronic obstructive pulmonary disease	0.000103	0.000201	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000102	0.000199	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000101	0.000197	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	9.88e-05	0.000193	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	9.43e-05	0.000185	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.37e-05	0.000183	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—ALB—chronic obstructive pulmonary disease	9.33e-05	0.000183	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	9.01e-05	0.000176	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—NOS3—chronic obstructive pulmonary disease	8.92e-05	0.000175	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.88e-05	0.000174	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—NOS2—chronic obstructive pulmonary disease	8.58e-05	0.000168	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.99e-05	0.000156	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—ALB—chronic obstructive pulmonary disease	7.61e-05	0.000149	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.6e-05	0.000149	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—NOS3—chronic obstructive pulmonary disease	7.28e-05	0.000142	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.23e-05	0.000141	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—SERPINE1—chronic obstructive pulmonary disease	7.22e-05	0.000141	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—NOS3—chronic obstructive pulmonary disease	6.9e-05	0.000135	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.49e-05	0.000127	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—ALB—chronic obstructive pulmonary disease	6.04e-05	0.000118	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.96e-05	0.000116	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.84e-05	0.000114	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—NOS3—chronic obstructive pulmonary disease	5.78e-05	0.000113	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.9e-05	9.59e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—TGFB1—chronic obstructive pulmonary disease	4.56e-05	8.92e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.49e-05	8.78e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—EGFR—chronic obstructive pulmonary disease	4.47e-05	8.75e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—IL6—chronic obstructive pulmonary disease	3.44e-05	6.72e-05	CbGpPWpGaD
